- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06213142
Developing the Unified Protocol-Single Session Experience Platform for Adolescent Mental Health (CBToolkit)
January 9, 2024 updated by: 3-C Institute for Social Development
This SBIR Phase I proposal will develop and test the acceptability and feasibility of a new suite of digital Single-Session Interventions, specifically applying Unified Protocol core principles for emotional disorders, to produce a highly accessible, engaging, and scalable product to help address the clinical needs of youth.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
This project proposes develop a suite of Single Session Intervention (SSI) modules using the Unified Protocol (UP) core principles.
For Phase I, the team will develop two SSI modules from UP: Awareness of Physical Sensations and Emotional Experiences, and Being Flexible in Your Problem Solving.
For the acceptability test (Specific Aim 2), investigators will recruit 60 youth who are screened as eligible based on the internalizing subscale of the Pediatric Symptom Checklist.
Caregivers/parents of youth will be recruited using targeted social media advertisements, where they can view a brief study description and complete the eligibility screener.
If interested, caregivers can provide contact information for the study team to conduct consent and assent processes.
Following consent and enrollment, participants will receive private login information to access the prototype and study materials.
First, participants will complete pre-surveys that collect demographic information and responses to the Revised Children's Anxiety and Depression Scale (RCADS).
Next, participants will take a brief survey to assess knowledge of intervention concepts presented in the first module: Mindful Awareness.
Then, they will engage with the module and provide feedback on the quality of its components.
Then, they will complete the knowledge assessment again.
Participants will complete the same process for the second module: Flexible Problem Solving (pre knowledge check, review, rate the quality, and post knowledge check).
Participants will complete a product evaluation to rate their overall experience with the prototype (quality, usability, innovation, feasibility, and value) and the degree they advocate for full product development.
Finally, participants will take the RCADS at the end of the review period.
There will also be an opportunity for participants to participate in a brief feedback call to provide additional feedback.
Study Type
Interventional
Enrollment (Actual)
57
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27713
- 3C Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- be ages 13 to 17 years old
- be willing and available to take part in the study requirements
- be fluent in English
- have access to the internet with a mobile device or personal computer
- have parent permission
- screen as eligible according to the internalizing subscale from the Pediatric Symptom Checklist
Exclusion Criteria:
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: CBToolkit
CBToolkit includes two SSI modules: (1) Mindful Awareness, with the goal of increasing awareness and tolerance of physical sensations and emotional experiences using mindfulness practices and tips and (2) Flexible Problem Solving, with the goal of promoting cognitive flexibility, applying problem-solving strategies in difficult scenarios, and learning to modify behavioral action tendencies.
|
CB Toolkit Mindful Awareness module to increase awareness and tolerance of physical sensations and emotional experiences using mindfulness practices.
The module involves videos with motion graphics, video demos, voiceover, music, and sound effects intermixed throughout with a variety of interactive exercises tailored to specific core components.
The module aims to establish understanding of the intervention concept (psychoeducation), increase self-efficacy in mindfulness skills via active practice and personalized feedback, and facilitate self-reflection and understanding of strengths and improvement areas related to mindfulness.
CBToolkit Flexible Problem Solving module to promote cognitive flexibility, applying problem-solving strategies in difficult scenarios, and learning to modify behavioral action tendencies.
Videos and activities will be tailored to provide examples of effective problem-solving techniques and provide personalized reinforcing and/or scaffolded feedback.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Program Feedback Scale for Adolescents
Time Frame: 2 week followup post module review
|
Adolescents will complete this 12-item measure, rating the extent to which they agree with statements about the usability, acceptability, and feasibility of the CBToolkit modules.
The measure includes 9 Likert items and 3 open-ended items.
Responses to the Likert items range from 1 (Really Disagree) to 5 (Really Agree).
Total scores are based on the Likert items are range from 0 to 45. Higher scores reflect more positive opinions.
|
2 week followup post module review
|
Module Knowledge
Time Frame: Average of 2 weeks apart, as pre- and post-tests
|
Adolescents will complete this 9-item measure to determine what they know about key concepts taught in the CBToolkit module prior to and following review of the modules.
The measure includes 9 multiple choice items with a 1 correct response per item.
Total scores are based on the number of items with correct responses and range from 0 to 9. Higher scores reflect more correct responses.
|
Average of 2 weeks apart, as pre- and post-tests
|
Revised Children's Anxiety and Depression Scale- Shortened
Time Frame: Average of 2 weeks apart, as pre- and post-tests
|
Adolescents will complete the shortened 11-item version of this measure to assess levels of anxiety and depression prior to and following review of the modules.
The measure includes 11 Likert items.
Responses to the Likert items range from 0- Never to 3- Always.
Total scores are based on the Likert items are range from 0 to 33.
Higher scores reflect more severe symptoms.
|
Average of 2 weeks apart, as pre- and post-tests
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Usage Metrics from the CBToolkit system for adolescents
Time Frame: The period in which adolescents interact with the system, approximately 2 weeks
|
The CBToolkit software will tracks progress through the modules, and the length of time spent on each sections of the module.
These metrics are measured in seconds.
A longer time generally indicates more time spent with the content.
|
The period in which adolescents interact with the system, approximately 2 weeks
|
Feedback interviews with adolescents
Time Frame: 15-minutes, completed after the test of the CBToolkit system
|
Adolescents will participate in individual interviews.
They will be asked about their experience with the CBToolkit, strengths and weaknesses of CBToolkit, and challenges to using CBToolkit.. Comments will be combined and grouped based on themes in a qualitative summary.
|
15-minutes, completed after the test of the CBToolkit system
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Melissa DeRosier, PhD, 3C Institute
- Principal Investigator: Jill Ehrenreich-May, PhD, University of Miami
- Principal Investigator: Jessica Schleider, PhD, StoneyBrook University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2023
Primary Completion (Actual)
August 31, 2023
Study Completion (Actual)
August 31, 2023
Study Registration Dates
First Submitted
December 29, 2023
First Submitted That Met QC Criteria
January 9, 2024
First Posted (Estimated)
January 19, 2024
Study Record Updates
Last Update Posted (Estimated)
January 19, 2024
Last Update Submitted That Met QC Criteria
January 9, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3CG078
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States